HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HealthCare Global Enterprises Ltd (HCG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8043
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiation oncology services, surgical oncology services, and others. It offers other services such as integrated molecular pathology services, accurate diagnosis treatment services, 3 TMRI services, ABVS services, digital mammogram services, PET CT scanning services and accurate pathological diagnosis services, among others. HCG provides medical oncology services such as haemato oncology, paediatric oncology, breast health centre, preventive oncology, day care chemotherapy, patient counseling, integrative oncology services, and others. The company offers radiation oncology services such as brachytherapy, cyberknife robotic surgery, hyperthermia services, and others. It operates through a network of hospitals across India. HCG is headquartered in Bangalore, Karnataka, India.

HealthCare Global Enterprises Ltd (HCG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Temasek Invests US$27 Million In HealthCare Global Enterprises 11
Partnerships 12
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
Merger 13
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
Equity Offering 14
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
Acquisition 17
HealthCare Global to Acquire 12% Stake in International Stemcell for USD0.1 Million 17
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 18
HealthCare Global Enterprises Ltd – Key Competitors 19
HealthCare Global Enterprises Ltd – Key Employees 20
HealthCare Global Enterprises Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Temasek Invests US$27 Million In HealthCare Global Enterprises 11
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
HealthCare Global to Acquire 12% Stake in International Stemcell for USD0.1 Million 17
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 18
HealthCare Global Enterprises Ltd, Key Competitors 19
HealthCare Global Enterprises Ltd, Key Employees 20
HealthCare Global Enterprises Ltd, Other Locations 21

List of Figures
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mizuho Financial Group Inc
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Data Corp (FDC):企業の財務・戦略的SWOT分析
    First Data Corp (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Promius Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Promius Pharma LLC (Promius Pharma), a subsidiary of Dr. Reddy's Laboratories Ltd, is a designer of personal and practical health care solutions that provides dermatology and neurology products. The company provides dermatology and neurology products. Its products include clocortolone pivala …
  • Histogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Regenicin Inc (RGIN):企業の財務・戦略的SWOT分析
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Aero Precision Industries, Inc.:企業の戦略・SWOT・財務情報
    Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Formycon AG (FYB):企業の財務・戦略的SWOT分析
    Summary Formycon AG (Formycon) formerly Nanohale AG is a biopharmaceutical company that develops biosimilar drugs candidates. The company offers biopharmaceutical imitation products for global recovery. It provides four biosimilar products in pre-clinical and clinical testing phases. Formycon’s pipe …
  • Quadra – Power Generation:発電所・企業SWOT分析
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Ribomic Inc (4591):製薬・医療:M&Aディール及び事業提携情報
    Summary Ribomic Inc (Ribomic), a subsidiary of Otsuka Pharmaceutical Co Ltd, is a biopharmaceutical venture company. The company develops molecular targeted pharmaceutical drugs using RNA aptamers. Its technology includes RiboART system a platform technology to treat therapeutic aptamers. Ribomic’s …
  • Ameren Corporation (AEE):電力:M&Aディール及び事業提携情報
    Summary Ameren Corporation (Ameren) is a public utility holding company that generates, transmits and distributes electricity; and transmits and distributes natural gas through its subsidiaries. The company generates electricity through varied energy sources such as coal, nuclear, hydro, solar, natu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆